These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35277831)

  • 21. Calcineurin inhibitors versus cyclophosphamide for idiopathic membranous nephropathy: A systematic review and meta-analysis of 21 clinical trials.
    Qiu TT; Zhang C; Zhao HW; Zhou JW
    Autoimmun Rev; 2017 Feb; 16(2):136-145. PubMed ID: 27988429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy.
    Zou H; Jiang F; Xu G
    Intern Med J; 2020 May; 50(5):612-619. PubMed ID: 31389094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New-Onset Diabetes Mellitus in Patients with Idiopathic Membranous Nephropathy Undergoing Tacrolimus and Low-Dose Corticosteroid Therapy.
    Shao L; Jin J; Ye B; Xu B; Li Y; Gong J; Zhang J; Chen M; He Q
    Kidney Blood Press Res; 2019; 44(6):1352-1362. PubMed ID: 31645044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis.
    Liu D; Yang Y; Kuang F; Qing S; Hu B; Yu X
    Int Immunopharmacol; 2019 May; 70():354-361. PubMed ID: 30852290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial.
    Chen M; Li H; Li XY; Lu FM; Ni ZH; Xu FF; Li XW; Chen JH; Wang HY;
    Am J Med Sci; 2010 Mar; 339(3):233-8. PubMed ID: 20220333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrolimus combined with corticosteroids in idiopathic membranous nephropathy: a randomized, prospective, controlled trial.
    Xu J; Zhang W; Xu Y; Shen P; Ren H; Wang W; Li X; Pan X; Chen N
    Contrib Nephrol; 2013; 181():152-62. PubMed ID: 23689577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
    Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D
    PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
    Li X; Lv R; He Q; Li H; Du X; Lin W; Li Q; He X; Wang S; Chen J
    J Nephrol; 2008; 21(4):584-91. PubMed ID: 18651550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials.
    Chen Y; Schieppati A; Cai G; Chen X; Zamora J; Giuliano GA; Braun N; Perna A
    Clin J Am Soc Nephrol; 2013 May; 8(5):787-96. PubMed ID: 23449768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population.
    Lin S; Li HY; Zhou T; Lin W
    Drug Des Devel Ther; 2019; 13():2305-2330. PubMed ID: 31371924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of Rituximab and Low-dose Tacrolimus in the Treatment of Refractory Membranous Nephropathy: A Retrospective Cohort Study.
    Chen X; Jiao S; Li S; Li J; Li P; Song F; Yan Z
    Balkan Med J; 2023 Jul; 40(4):287-293. PubMed ID: 37260416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis.
    Chen M; Zhang X; Xiong Y; Xu G
    Int Urol Nephrol; 2023 Mar; 55(3):641-651. PubMed ID: 36161550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Efficacy and Safety of Tacrolimus, Cyclosporin A, Mycophenolate Mofetil, Cyclophosphamide, and Corticosteroids as Induction Therapy for Membranous Lupus Nephritis: A Network Meta-Analysis.
    Lee YH; Song GG
    Pharmacology; 2022; 107(9-10):439-445. PubMed ID: 35609529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.
    Xie G; Xu J; Ye C; Chen D; Xu C; Yang L; Ma Y; Hu X; Li L; Sun L; Zhao X; Mao Z; Mei C
    PLoS One; 2012; 7(9):e44330. PubMed ID: 22957065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of ultra-low dose rituximab and low dose tacrolimus versus tacrolimus alone in the treatment of non-responsive idiopathic membranous nephropathy: a Chinese retrospective cohort study.
    Zhu F; Chu X; Guo Y; Li Y; Cao C; Wu J; Xu H; Deng X; Li J; Liu X; Yao Y; Zeng R
    Am J Transl Res; 2021; 13(7):7622-7631. PubMed ID: 34377239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of rituximab in the treatment of membranous nephropathy: A systematic review and meta-analysis.
    Lu W; Gong S; Li J; Luo H; Wang Y
    Medicine (Baltimore); 2020 Apr; 99(16):e19804. PubMed ID: 32311997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy of three regimens (cyclosporine, tacrolimus, and cyclophosphamide) combined with steroids for the treatment of idiopathic membranous nephropathy.
    Ruo-Ji C; Fang X; Zhen-Shuang D; Yu-Lin Z; Zi-Li Z; Wei-Yuan L
    Nefrologia (Engl Ed); 2022; 42(6):671-679. PubMed ID: 36402685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of diabetes with failure to achieve complete remission of idiopathic membranous nephropathy.
    Xie H; Li C; Wen Y; Ye W; Cai J; Li H; Li X; Li X
    Int Urol Nephrol; 2020 Feb; 52(2):337-342. PubMed ID: 31820359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.
    Choi JY; Kim DK; Kim YW; Yoo TH; Lee JP; Chung HC; Cho KH; An WS; Lee DH; Jung HY; Cho JH; Kim CD; Kim YL; Park SH
    J Korean Med Sci; 2018 Feb; 33(9):e74. PubMed ID: 29441742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Safety of Tacrolimus Versus Cyclophosphamide for Primary Membranous Nephropathy: A Meta-Analysis.
    Zhu LB; Liu LL; Yao L; Wang LN
    Drugs; 2017 Feb; 77(2):187-199. PubMed ID: 28084563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.